![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication February 24, 2005.
Revised April 13, 2005.
Accepted for publication April 14, 2005.
We recently found that a polypeptide, the C-terminal of Clostridium perfringens enterotoxin (C-CPE), was a novel type of drug absorption enhancer. The C-terminal of C-CPE is thought to play a role in the binding of C-CPE to its receptor, claudin-4. But, the function of the N-terminal of C-CPE is unclear. In the present study, we evaluated the role of the N-terminal domain of C-CPE in jejunal absorption and claudin-4 binding. The treatment of rat jejunum with C-CPE resulted in enhanced absorption of dextran with a molecular weight of 4,000 Da. But, treatment with C-CPE220, which lacks the 36 N-terminal amino acids of C-CPE, did not enhance jejunal absorption. C-CPE had affinity for claudin-4 in rat jejunum lysates and Caco-2 lysates, but C-CPE220 did not. Interaction of C-CPE with the recombinant extracellular domain 2 of human claudin-4 (EC2hCld-4), which is the putative binding site for C-CPE, was observed; but, C-CPE220 had no affinity for EC2hCld-4. To investigate the effect of C-CPE220 on the barrier function of tight junctions, we measured transepithelial electric resistance (TER) in C-CPE- or C-CPE220-treated Caco-2 monolayer cells. Although C-CPE decreased TER in Caco-2 monolayer cells, C-CPE220 did not disrupt the barrier function of tight junctions. Taken together, these results indicate that the 36 N-terminal amino acids of C-CPE may be necessary for the enhanced absorption mediated by C-CPE and play a partial role in binding to claudin-4.
Key words:
caco-2, claudin-4, clostridium perfringens enterotoxin, dextran, jejunal absorption, transepithelial electric resistance
This article has been cited by other articles:
![]() |
J. Ling, H. Liao, R. Clark, M. S. M. Wong, and D. D. Lo Structural Constraints for the Binding of Short Peptides to Claudin-4 Revealed by Surface Plasmon Resonance J. Biol. Chem., November 7, 2008; 283(45): 30585 - 30595. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Smedley III, J. Saputo, J. C. Parker, M. E. Fernandez-Miyakawa, S. L. Robertson, B. A. McClane, and F. A. Uzal Noncytotoxic Clostridium perfringens Enterotoxin (CPE) Variants Localize CPE Intestinal Binding and Demonstrate a Relationship between CPE-Induced Cytotoxicity and Enterotoxicity Infect. Immun., August 1, 2008; 76(8): 3793 - 3800. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ebihara, M. Kondoh, N. Hasuike, M. Harada, H. Mizuguchi, Y. Horiguchi, M. Fujii, and Y. Watanabe Preparation of a Claudin-Targeting Molecule Using a C-Terminal Fragment of Clostridium perfringens Enterotoxin J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 255 - 260. [Abstract] [Full Text] [PDF] |
||||